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Abstract
Background: Persistent musculoskeletal pain and psychological sequelae following minor motor vehicle collision
(MVC) are common problems with a large economic cost. Prospective studies of pain following MVC have
demonstrated that demographic characteristics, including female gender and low education level, and psychological
characteristics, including high pre-collision anxiety, are independent predictors of persistent pain. These results have
contributed to the psychological and social components of a biopsychosocial model of post-MVC pain pathogenesis,
but the biological contributors to the model remain poorly defined. Recent experimental studies indicate that
genetic variations in adrenergic system function influence the vulnerability to post-traumatic pain, but no studies
have examined the contribution of genetic factors to existing predictive models of vulnerability to persistent pain.
Methods/Design: The Project CRASH study is a federally supported, multicenter, prospective study designed to
determine whether variations in genes affecting synaptic catecholamine levels and alpha and beta adrenergic
receptor function augment social and psychological factors in a predictive model of persistent musculoskeletal
pain and posttraumatic stress disorder (PTSD) following minor MVC. The Project CRASH study will assess pain, pain
interference and PTSD symptoms at 6 weeks, 6 months, and 1 year in approximately 1,000 patients enrolled from 8
Emergency Departments in four states with no-fault accident laws.
Discussion: The results from this study will provide insights into the pathophysiology of persistent pain and PTSD
following MVC and may serve to improve the ability of clinicians and researchers to identify individuals at high risk
for adverse outcomes following minor MVC.
Background
During recent decades, emergency medicine research has
continued to expand in scope and increasingly focuses
not only on immediate patient outcomes but also on
patient outcomes well beyond emergency department
(ED) departure. Inception cohort studies examining long
term outcomes among patients experiencing acute illness
or trauma benefit from enrolling patients in the ED
because it is the site of their initial care. In addition, for
many patients the ED serves as their only source of care
[1,2]. For these reasons, an increasing number of large
scale multidisciplinary research projects have utilized
ED-based inception cohorts to evaluate long term out-
comes after screening, risk stratification, or interventions
performed in the ED [3-8].
This report describes the methods of Project CRASH,
an example of a type of ED-based inception cohort
study which we anticipate will become increasingly
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common in the future. Project CRASH uses an ED-
based inception cohort to enroll patients soon after
injury, and examines genetic factors associated with
long term patient outcomes. A prior study examined
genetic variations in alcohol metabolism as a risk factor
for trauma center admission [9], but to our knowledge
no studies have used ED-based inception cohorts to
examine genetic characteristics associated with long
term patient outcomes in the hope of advancing under-
standing of disease pathophysiology.
The goal of Project CRASH is to gain new insights into
the pathophysiology of persistent pain and psychological
sequelae after motor vehicle collision (MVC). Approxi-
mately 6 million people present to United States EDs
each year for care after MVC. More than 90% of these
individuals do not have serious physical injury and are
discharged to home after ED evaluation [10]. However,
persistent post-MVC pain (most commonly neck pain) is
experienced by 10-20% of individuals after “minor” MVC
[11,12] with significant associated economic cost [13].
The mechanisms by which patients develop acute and
chronic pain after minor MVC remain poorly understood
[14]. Interestingly, increasing evidence suggests that
stress systems, such as the sympathetic nervous system
and adrenomedullary hormonal system, may modulate
neurosensory processing after trauma exposure, contri-
buting to the development of chronic pain [15]. If a parti-
cular physiologic system is involved in the pathogenesis
of a disorder, then genetic variations influencing the
function of this system would be expected to be asso-
ciated with vulnerability to develop the disorder and to
improve prediction of which individuals will develop this
disorder. These concepts are the rationale of the Project
CRASH, R01AR056328, “Genetic Predictors of Acute




The CRASH study is a prospective multicenter observa-
tional cohort study of patients experiencing minor MVC.
Study participants are enrolled at research network ED
sites and receive initial interview evaluation at the time of
the ED visit. Study participant follow-up assessments are
performed at 6 weeks, 6 months, and one year. The study
research network (“TRYUMPH Research Network”)
includes Baystate Medical Center, Massachusetts General
Hospital, North Shore University Hospital, Shands Jack-
sonville Hospital, Spectrum Health Butterworth Hospital,
St. Joseph Mercy Hospital, and William Beaumont
Hospital (2 ED sites). All eight EDs are located in states
with “no fault” insurance laws that restrict the right to
seek recovery from other parties through the civil-justice
system. The study is restricted to states with no-fault
accident laws to minimize the likelihood of legal action
following MVC, which is a potential confounding factor
influencing patient outcome [16]. The data coordinating
center for the study is located at the University of North
Carolina, Chapel Hill, NC, USA.
Inclusion Criteria
Patients age 18 to 65 who present to the ED within
24 hours after minor MVC and who are unlikely to
require admission are screened for eligibility. Patients with
injuries likely to require hospitalization, fractures (other
than small bone fractures), major lacerations (defined as a
laceration more than 20 cm in length or more than four
lacerations requiring sutures), intracranial injury, or spinal
injury (defined as vertebral fracture or dislocation, or new
neurologic deficit) are excluded. Patients who are deemed
eligible but subsequently admitted overnight to the hospi-
tal are excluded. Patients who go to an ED observation
area for a brief period (e.g. “6 hour rule out”) remain eligi-
ble. Patients are excluded if they are prisoners, pregnant,
not alert and oriented, or unable to read and understand
English. Patients are also excluded if they take b-receptor
antagonist or if they take opioids on a daily basis above a
total daily dose of 20 mg of oxycodone or equivalent. In
addition, due to the effects of ethnicity on genetic risk fac-
tor assessment (population stratification bias [17] that may
require different ethnicities to be analyzed separately) and
budget restrictions limiting sample size, enrollment is lim-
ited to European Americans. After assessment for eligibil-
ity, signed informed consent is obtained from all patients
enrolled in the study.
Patient screening and consent
Patient screening and assessment are performed using
web-based study assessment forms. Research assistants
(RAs) complete a web-based patient screening question-
naire for each patient presenting to the ED for evalua-
tion after MVC during day and evening hours when
study site research team members are staffing the ED.
The screening form prompts the RA to complete a ser-
ies of questions. If participants are eligible for participa-
tion based on screening questionnaire responses, the RA
is automatically advanced to the ED assessment inter-
view web survey. If participants are not eligible, the rea-
son for ineligibility is stored by the system. If patients
are eligible, they are offered participation in the study.
Signed informed consent is obtained from willing
participants.
Blood collection for DNA
After consent is obtained, a single blood sample (8.5 cc)
is collected using a PAXgene DNA storage tube (http://
www.preanalytix.com). When possible, this blood sample
is obtained when blood is collected as part of the
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patient’s medical evaluation, to avoid additional phlebot-
omy. Each blood specimen is labeled with a barcode
sticker, which serves as a unique identifier for the sam-
ple. After the barcode sticker is placed on the sample,
the barcode is scanned using a reader wand which
enters the barcode number into a web-based tracking
system and links the number with the participant’s iden-
tification number. The barcode is also scanned at the
time of shipment from the study site to the genotyping
facility, and at the time of receipt by the genotyping
facility, to maintain blood sample chain of custody.
PAXgene DNA storage tubes are stored at 4°C (standard
refrigeration) for up to two weeks [18] at the study site
prior to batch shipment to Cogenics, Inc., (Morrisville,
NC).
ED Interview
ED assessments are conducted by trained research assis-
tants using a standardized web-based questionnaire on
laptop computer. Back-up paper copies are used by RAs
if hospital wireless internet service is unavailable. The
ED interview begins with the collection of patient con-
tact information, including information on two potential
alternative contacts. Subsequent interview assessments
include the collection of detailed information regarding
the collision event, current somatic and psychological
symptoms, past somatic and psychological symptoms,
and general health and medication use (Table 1; Addi-
tional Files 1 and 2). Participants are compensated $80
for completing the ED evaluation.
Data Extraction
During the week following the completion of the ED
interview, study site RAs extract data from the partici-
pant’s medical record using a standardized web-based
data extraction form. Fields on this data extraction form
provide explicit definitions of all variables. Information
collected includes chief complaint, vital signs, past medi-
cal history, medications given in the ED and prescribed
at discharge, injuries described in the medical record,
and results of radiologic studies performed in the ED.
All aspect of the emergency medical record including
physician notes, nursing notes, and physician orders
were used for completion of data extraction. Injury
information was used to generate Abbreviated Injury
Severity Scores [19].
Follow-Up Assessments
Follow-up assessments are completed at 6 weeks, 6
months, and 1 year post-enrollment with assessment
made during a 4 week window for each follow-up time
point (Additional File 3). Information collected at each
follow-up is identical, except that drug and alcohol use
is reassessed at only the 6 month and 1 year time
points. Participants are able to complete the interview
online, by telephone, or by mail. Information packets
are sent that remind participants that it is time to com-
plete their next assessment. These packets include the
actual questionnaires to be completed during the inter-
view; if participants choose to complete their assessment
via mail they can do so or they can follow along with
the questionnaires at home during a telephone inter-
view. Follow up interviews are scheduled at a time (day
or evening) that is convenient for the participant. Three
and nine months after enrollment, participants also
complete a contact information update via mail. Assess-
ments collect detailed information regarding re-injury or
new injury events, as well as information regarding
involvement in a litigation or disability claim, missed
work or other activities, somatic symptoms (including
pain symptoms), psychological symptoms, and func-
tional interference due to pain (Table 1). For any body
region for which pain is reported, the patient is also
asked whether the pain is due to (began after) the MVC.
Health care utilization assessments are also evaluated
and include: medication use; visits to the ED, primary
physician, specialist physicians, or alternative medicine
providers; and hospitalization. Participants are compen-
sated $50, $60, and $70 after completing the 6 week, 6
month, and 1 year follow-up interviews, respectively.
Protection of Patient Privacy
A number of methods are used to maintain the confi-
dentiality of study data. A Certificate of Confidentiality
has been obtained from the National Institutes of Health
to protect identifiable research information from forced
disclosure [20]. All research assistants involved in the
study complete training in the protection of patient con-
fidentiality through the Collaborative Institutional Train-
ing Initiative [21]. Signed consent is obtained from all
patients to perform all assessments and to allow future
analysis of de-identified blood specimens. A unique
patient identifier is used to link patient identifying infor-
mation to results of questionnaires and genetic informa-
tion, and all analyses are conducted on de-identified
data. The study has been approved by the institutional
review boards of all participating institutions.
Sample Size Estimate
Sample size was calculated to determine the number of
patients needed to assess the influence of selected adre-
nergic system-related genes on the presence of persis-
tent moderate or severe neck pain with adequate power.
Because the genes to be assessed contain approximately
59 haplotypes, a Bonferroni corrected alpha was set at.
00085 (.05/59). Estimates of the number of patients
needed to identify the effect sizes obtained for candidate
haplotypes examined in our pilot data ranged from 171
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to 1,295 (alpha = .00085, beta = .8). These estimates
were believed to be conservative because 1) the inclu-
sion of non-genetic factors should reduce the unex-
plained variance in the model and increase power to
detect the influence of genetic factors, 2) analyses will
utilize repeated-measures logistic regression, which will
increase power, and 3) for some genes, only specific risk
haplotypes will be assessed so the actual number of hap-
lotypes will likely be less than 59. Based on these ana-
lyses, recruitment of 936 patients is planned, in order to
achieve at least 795 patients completing follow-up time
points (estimated follow-up rate of 85%).
Data Analysis
DNA is extracted (average PAXgene DNA yield 150 μg
to 500 μg) and targeted genotyping of single nucleotide
polymorphisms (SNPs) is performed using the Seque-
nom (Sequenom, Inc., San Diego, CA) platform. When
possible, a haplotype-based approach to genetic analyses
is utilized, because previous studies suggest that a haplo-
type-based approach to genetic analyses is often most
useful. This is because the overall functional state of a
gene may not be easily deduced from information
regarding a single SNP [22]. For example, haplotype-
dependent secondary RNA structure can have a much
greater influence on function than a functional SNP
within this haplotype [22]. To construct haplotypes,
both functional SNPs previously shown to affect gene
function and also tag SNP markers within each gene
locus (to capture haplotypic diversity) are genotyped.
Two hapmap samples, for which the entire genome
sequence is known, and 2 repeat samples are included
in each genotyping batch to assess genotypic accuracy
and reliability. Haplotypes are then constructed for each
of the genetic risk factors assessed using the Haploview
software program. Polymorphisms of interest include
genetic variations influencing catecholamine levels
(monoamine oxidase A, monoamine oxidase B, norepi-
nephrine transporter, catechol-O-methyltransferase) and
adrenoreceptor function (a1A, a1B, a1D, a2A, a2B,
a2C, b1, b1). Quality control of genetic data includes
assessment of call rates for each SNP, identification of
samples with call rates < 90%, and test of Hardy-Wein-
berg equilibriums for each locus. Genetic data results
are then merged with phenotypic data and analyzed
using standard statistical methods. Primary and second-
ary analyses evaluate genotypic and phenotypic predic-
tors of persistent pain and psychological sequelae.
Discussion
ED-based inception cohort studies such as Project
CRASH, which combine genotypic and phenotypic data
collection, are likely to become increasingly common for
several reasons. First, as the cost of genotyping
Table 1 Study question domains, specific measures, and times of assessment.
Domain Measure ED 1 M 6 M 1 Y*
MVC injury events Questionnaire ●
Current pain symptoms NRS**, Regional Pain Scale ● ● ● ●
Scale[25]
Optimism Life Orientation Test-Revised[26] ●
Current whiplash symptoms Quebec classification[11] ●
Current somatic symptoms Standardized questionnaire ● ● ● ●
Distress after MVC Peritraumatic Distress Inventory[27] ●
Dissociative symptoms after MVC Critical Events Perception Inventory[28] ●
Catastrophizing Pain Catastrophizing scale[29] ●
Current somatic symptoms Somatic symptom interview[30]
Pre-MVC General health SF-12[31] ●
Pre-MVC Anxiety symptoms STPI¥ Form Y[32] ●
Pre-MVC Depressive symptoms CES-D°[33] ●
PTSD† symptoms Impact of Event Scale-Revised[34] ● ● ●
General health SF-12[31] ● ● ●
Demographic information Standard items ● ● ●
Medication Use Standard items ● ● ● ●
Alcohol and drug use TWEAK[35], Substance Abuse Outcomes Module[36] ● ● ●
New injury or re-injury Standard Items ● ● ●
Pain interference Brief Pain Inventory (pain interference questions)[37] ● ● ●
Service utilization, disability/litigation claims Standard items ● ● ●
*ED = Emergency Department, 1 M = 1 month, 6 M = 6 months, 1 Y = w year, **NRS = Numeric rating scale, ¥State Trait Personality Inventory, †PTSD =
Posttraumatic Stress Disorder, °Center for Epidemiologic Studies Depression Scale
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continues to decline, and as our knowledge of genetic
polymorphisms influencing physiologic processes con-
tinues to increase, the value (cost effectiveness) of these
studies will continue to grow. Second, genetic (and epi-
genetic) techniques represent one useful method to
address a critical shortfall in current medical knowledge:
our ability to identify those at high risk for a particular
disease outcome has rapidly outpaced our knowledge of
the mechanisms mediating the outcome. That is,
increasingly we can identify “who”, but we do not know
“why”. Including genetic factors in traditional epidemio-
logic studies enhances the ability of study findings to
yield clues regarding disease pathogenesis, by determin-
ing the physiologic systems or pathways contributing to
disease outcomes, and by determining the environmen-
tal conditions under which these outcomes occur (gene
× environment interactions). Further knowledge of the
physiologic systems which mediate disease outcomes has
the potential to enhance our ability to identify high-risk
individuals and/or to suggest novel preventive interven-
tions. These studies require relatively large number of
patients, which ED-based networks can provide.
To most rapidly bring the benefits of these types of
studies to our patients, organizations within academic
emergency medicine should continue to look for oppor-
tunities to bring knowledge of genetic epidemiologic
methods to emergency medicine researchers. The above
description of Project CRASH is hopefully useful in this
regard. Fortunately, the genetics field continues to grow
exponentially, with an increasing array of opportunities
to rapidly get “up to speed” regarding performing and
interpreting genetics studies. For example, there are
now a number of societies focused on genetic studies in
humans (e.g. Society for Human Genetics), and online
genetic education resources are available through the
National Human Genome Research Institute (http://
www.genome.gov/10000464), the Human Genome Pro-
ject (http://www.ornl.gov/sci/techresources/Human_-
Genome/posters/chromosome/), and other educational
organizations.
Difficulties and Potential Limitations
A current limitation of epidemiologic studies examining
genetic factors is that they often must be performed
within a particular ethnicity. As described above, Project
CRASH is limited to European Americans only. This is
because the prevalence of specific genetic variations
often varies between ethnicities. For example, haplotype
frequencies for COMT genes are different between Cau-
casians, African Americans, and Asians [23]. This neces-
sitates stratified analyses, and the size of each strata
must be large, often limiting a study to a single strata
within the context of the budget of a particular grant
mechanism.
Several methods are now available to address this pro-
blem of population stratification. One of them is princi-
pal components analysis of a set of ancestry-informative
markers (i.e. SNPs which have different frequencies
among populations from different regions) to identify
population ancestral heterogeneity [24]. However, the
accuracy of these methods vs. stratified analyses remains
a matter of debate. As with other areas of genetic
research, the only constant is that techniques and meth-
ods will continue to rapidly change.
Additional material
Additional file 1: CRASH Methods ED Assessment Part 1. Part 1 of
the 2 part survey administered in the Emergency Department.
Additional file 2: CRASH Methods ED Assessment Part 2. Part 2 of
the 2 part survey administered in the Emergency Department.
Additional file 3: CRASH Methods Follow-Up Questionnaire. The
survey administered at each follow-up interval.
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